You've seen the patient before: an adult presenting with severe dietary restriction, significant nutritional deficiency, and marked functional impairment. But the clinical picture doesn't fit anorexia nervosa. There's no body image disturbance, no fear of weight gain, no drive for thinness. Instead, you hear about lifelong sensory aversions, fear of choking or vomiting, or simply no appetite or interest in food. These patients often arrive with a trail of misdiagnoses: generalized anxiety disorder, IBS, somatic symptom disorder, or dismissed as "just picky eaters." What you're likely encountering is ARFID in adults, a diagnosis that remains systematically under-identified in adult populations despite its significant clinical impact.
Avoidant/Restrictive Food Intake Disorder (ARFID) was introduced in the DSM-5 to capture restrictive eating patterns not driven by weight or shape concerns. Yet nearly all ARFID research, clinical protocols, and training materials focus on pediatric and adolescent populations. This leaves adult-serving clinicians without a reliable framework for diagnosis or treatment, even as adult ARFID patients cycle through years of ineffective interventions before receiving appropriate care.
Why Adult ARFID Is Systematically Under-Identified
ARFID presents across three primary subtypes: sensory sensitivity (aversion to specific textures, tastes, smells, or appearances), fear of aversive consequences (anxiety about choking, vomiting, or gastrointestinal distress), and lack of interest in eating (low appetite or indifference to food). Each subtype manifests differently in adults compared to children, primarily because adults have spent years, sometimes decades, developing sophisticated compensatory strategies that mask the severity of their restriction.
An adult with sensory-based ARFID may have constructed an entire lifestyle around their limited food repertoire: ordering the same items at restaurants, declining social invitations that involve unfamiliar food settings, or relying on meal replacement supplements to meet basic nutritional needs. These adaptations can make the restriction appear less severe than it actually is, particularly when the patient has normalized their eating pattern and doesn't spontaneously report it as problematic.
Adults with fear-based ARFID often present first to gastroenterology or primary care with complaints of difficulty swallowing, nausea, or abdominal pain. By the time they reach behavioral health, they may have undergone extensive medical workups that failed to identify a structural cause. The anxiety component is real and often meets criteria for a separate anxiety disorder, but the restrictive eating pattern itself represents ARFID rather than a primary anxiety disorder with secondary food avoidance.
The lack-of-interest subtype is perhaps most easily overlooked in adults. These patients may report that they "forget to eat," feel no hunger cues, or find eating to be a chore. Without the developmental context of failure to thrive or growth faltering that triggers concern in children, adult clinicians may not recognize this as a diagnosable eating disorder requiring intervention.
Common Misdiagnoses and Clinical Flags
Before receiving an accurate ARFID diagnosis, adult patients typically accumulate a series of alternative diagnoses that capture pieces of the clinical presentation but miss the core eating disorder. Generalized anxiety disorder is frequently diagnosed when the predominant feature is fear of aversive consequences. Obsessive-compulsive disorder may be considered when patients describe rigid food rules or checking behaviors around food safety.
Irritable bowel syndrome and other functional gastrointestinal disorders are common misdiagnoses, particularly when patients describe genuine GI symptoms that have developed secondary to chronic dietary restriction and malnutrition. Somatic symptom disorder may be applied when multiple unexplained physical symptoms are present, failing to recognize that these symptoms stem from nutritional deficiency rather than psychological preoccupation with illness.
Several clinical flags should prompt an ARFID screen rather than defaulting to these alternative diagnoses. First, dietary restriction that predates the onset of anxiety or GI symptoms, particularly when the patient reports lifelong selective eating. Second, the absence of body image concerns or weight-related goals despite significant restriction. Third, nutritional consequences that are disproportionate to the patient's reported distress, suggesting long-standing normalization of inadequate intake.
Fourth, restriction patterns organized around sensory properties of food rather than caloric content or macronutrient composition. And fifth, functional impairment specifically related to eating situations: declining job opportunities that involve travel or client meals, relationship strain due to eating differences, or social isolation driven by food-related anxiety. When multiple eating disorder treatment programs have been tried without success, consider whether the patient was being treated for the wrong eating disorder.
DSM-5 Diagnostic Criteria and Adult-Specific Nuances
The DSM-5 outlines four criteria for diagnosing ARFID, emphasizing the absence of body image disturbance and ruling out other eating disorders or medical conditions as the cause. The core criterion is an eating or feeding disturbance manifested by persistent failure to meet appropriate nutritional and/or energy needs.
This failure must be associated with one or more of the following: significant weight loss or failure to achieve expected weight gain, significant nutritional deficiency, dependence on enteral feeding or oral nutritional supplements, or marked interference with psychosocial functioning. These features must be documented through comprehensive medical, nutritional, and psychological evaluation.
In adult populations, the weight and nutritional impact thresholds require careful interpretation. Adults with longstanding ARFID may have maintained a stable (though low) weight for years, making "significant weight loss" less applicable than in pediatric cases. Instead, clinicians should assess whether the patient's weight is significantly below what would be expected for their age and height, or whether they have a history of being unable to gain weight despite medical recommendations.
Nutritional deficiency in adults often manifests as specific micronutrient deficits: iron deficiency anemia, vitamin D insufficiency, B12 deficiency, or low bone density. These may develop silently over years and only be detected through laboratory screening. The dependence on oral supplements is particularly common in adult ARFID, as patients often discover protein shakes or meal replacement products as a way to meet caloric needs without confronting feared or aversive foods.
Documenting psychosocial impairment requires asking specific questions about how eating patterns affect daily functioning. Many adults with ARFID have organized their lives to minimize food-related distress, so impairment may not be immediately obvious. Ask about: career decisions influenced by eating limitations, romantic relationships affected by dietary differences, social activities declined due to food anxiety, travel restrictions based on food availability, and financial costs of maintaining a restricted diet through supplements or specific brands.
Validated Assessment Tools for Adult ARFID
Several validated instruments can aid in screening and assessing ARFID in adult populations. The Nine Item ARFID Screen (NIAS) is a brief self-report measure that assesses the three ARFID subtypes: picky eating (sensory sensitivity), appetite (lack of interest), and fear of aversive consequences. It provides dimensional scores for each subtype and has demonstrated good psychometric properties in adult samples.
The ARFID Impact Scale measures functional impairment across multiple domains and can help document the psychosocial criterion for diagnosis. Structured clinical interviews including the ARFID module of the Eating Disorder Examination (EDE) are available in adult, child, and parent versions and allow for systematic assessment of ARFID diagnostic criteria.
The Pica, ARFID, and Rumination Disorder Interview (PARDI) is another structured interview tool specifically designed to assess avoidant/restrictive eating patterns and differentiate ARFID from other feeding and eating disorders. These tools should be used alongside a thorough clinical interview that explores the developmental history of eating patterns, previous diagnoses and treatments, medical complications, and current functional impact.
Differentiating ARFID from anorexia nervosa is critical and usually straightforward when the right questions are asked. In anorexia nervosa, restriction is motivated by weight and shape concerns, fear of weight gain, or pursuit of thinness. Patients with anorexia nervosa typically have distorted body image and derive psychological reinforcement from achieving lower weights. In ARFID, restriction is motivated by sensory aversion, fear of negative consequences from eating, or lack of interest, with no investment in weight or body shape as a motivating factor.
Some adult patients may present with features of both disorders or transition from ARFID to anorexia nervosa during adolescence or young adulthood. In these cases, both diagnoses may be warranted if criteria for each are met independently. Understanding the full spectrum of eating disorders treated in specialized programs helps contextualize where ARFID fits within the broader eating disorder landscape.
Treatment Frameworks for Adult ARFID
Cognitive Behavioral Therapy for ARFID (CBT-AR) is a short-term, symptom-oriented therapy that focuses on beliefs, values, and cognitive processes maintaining the eating disorder. Originally developed and tested primarily in pediatric and adolescent populations, CBT-AR requires significant adaptation for adult patients who have lived with ARFID for decades.
The standard CBT-AR protocol includes psychoeducation about nutrition and the maintaining factors of ARFID, development of exposure hierarchies for feared or avoided foods, cognitive restructuring of unhelpful beliefs about food and eating, and behavioral experiments to test predictions about aversive consequences. For adults, these components must be delivered with attention to the patient's autonomy, longstanding coping strategies, and often ambivalent motivation for change.
Motivational interviewing techniques are essential when working with adult ARFID patients who may not spontaneously identify their eating pattern as problematic. Exploring the functional impairment, eliciting the patient's own reasons for considering change, and addressing ambivalence directly creates a stronger foundation for treatment engagement than simply prescribing exposure exercises.
Exposure hierarchies for adults need to account for the complexity of adult food environments and social contexts. Rather than focusing solely on expanding the variety of foods consumed, treatment should address: eating in restaurants, attending work functions involving food, traveling to locations with unfamiliar food options, and managing eating in romantic relationships. The hierarchy should be collaboratively developed and reflect the patient's own goals for functional improvement.
The role of the registered dietitian is central to adult ARFID treatment. The RD conducts nutritional assessment, identifies specific deficiencies requiring supplementation, develops meal plans that gradually expand dietary variety while ensuring adequate nutrition, and provides education about the physiological consequences of restriction. The RD also helps patients understand how chronic restriction may have altered their hunger and satiety cues, GI function, and metabolism.
Treatment focuses on weight restoration when indicated, preventing medical complications, and addressing mental health concerns and sensory aversions through a multidisciplinary approach. For adult patients, treatment duration is often longer than the typical 3-5 months cited for pediatric Family-Based Treatment for ARFID (FBT-ARFID), as adults must develop skills for independent eating without the scaffolding of parental involvement.
When implementing treatment, clinicians should develop comprehensive documentation practices that support appropriate reimbursement. Understanding billing codes and compliance requirements for eating disorder treatment ensures that adult ARFID patients can access the intensive services they often require.
Medical Comorbidities and Screening Requirements
Adult ARFID patients require comprehensive medical screening for complications that develop silently over years of nutritional inadequacy. Malnutrition in adults manifests differently than in children and may not be immediately apparent from weight or BMI alone. Screening should include complete blood count, comprehensive metabolic panel, lipid panel, thyroid function, vitamin D, vitamin B12, folate, iron studies, and zinc levels at minimum.
Bone density assessment via DEXA scan is indicated for adults with longstanding ARFID, particularly those with low body weight or amenorrhea in females. Osteopenia and osteoporosis can develop insidiously and represent serious long-term health consequences of chronic nutritional restriction. Cardiac monitoring including EKG and potentially echocardiogram should be considered for patients with significant malnutrition or rapid weight loss.
Gastrointestinal complications are common in adult ARFID and may include gastroparesis, constipation, early satiety, and altered gut microbiome. These complications can create a vicious cycle where GI symptoms reinforce food avoidance, which further impairs GI function. Medical management of these complications should proceed alongside behavioral treatment, with recognition that some GI symptoms will improve with nutritional rehabilitation.
Refeeding syndrome is a risk when initiating nutritional rehabilitation in severely malnourished adults with ARFID. Clinicians should be familiar with refeeding protocols, including gradual caloric advancement, phosphorus monitoring and repletion, and cardiac monitoring during the refeeding phase. Some adult ARFID patients require higher levels of care initially to safely manage medical stabilization.
Autism Spectrum Disorder and ARFID in Adults
Sensory-based ARFID is disproportionately prevalent in autistic adults, reflecting the sensory processing differences inherent to autism spectrum disorder. For autistic adults, food-related sensory aversions are often part of a broader pattern of sensory sensitivities affecting multiple domains. The texture, temperature, appearance, smell, and even sound of foods can trigger genuine distress that non-autistic clinicians may underestimate.
When ARFID co-occurs with autism in adults, treatment priorities shift toward accommodation and harm reduction rather than aggressive dietary expansion. The goal is ensuring adequate nutrition and preventing medical complications while respecting the neurological basis of sensory differences. Forcing exposure to highly aversive foods is unlikely to be successful and risks damaging the therapeutic relationship.
Accommodation-based approaches include: identifying nutritionally complete foods within the patient's accepted repertoire, using nutritional supplements to fill gaps, modifying food presentation to reduce sensory triggers, and focusing exposure work on foods that are closer to already-accepted items on the sensory spectrum. Environmental accommodations such as controlling lighting, noise, and social pressure during meals can significantly reduce mealtime distress for autistic adults with ARFID.
Clinicians working with autistic adults should also assess for alexithymia (difficulty identifying and describing emotions), which is common in autism and can complicate traditional CBT approaches that rely on emotional awareness and regulation. Adaptations may include more concrete, behavioral interventions and less emphasis on identifying emotional triggers or cognitive distortions.
Treatment planning should involve the patient as an expert on their own sensory experience. Autistic adults often have sophisticated understanding of their sensory profiles and can articulate which accommodations are most helpful. Collaborative goal-setting that prioritizes the patient's functional outcomes rather than clinician-defined "normal eating" is essential for engagement and success.
Moving Toward Better Identification and Treatment
Adult ARFID remains significantly under-recognized despite its prevalence and impact. Clinicians serving adult populations need updated training that goes beyond pediatric-focused ARFID content and addresses the unique presentation, assessment, and treatment considerations for adults who have lived with restrictive eating for years or decades.
Systematic screening for ARFID should be incorporated into intake assessments for eating disorder programs, anxiety and OCD treatment settings, gastroenterology practices, and autism services for adults. Brief screening tools like the NIAS can be administered quickly and identify patients who warrant more comprehensive ARFID assessment.
Treatment programs need to develop adult-specific ARFID protocols that move beyond adapting pediatric interventions. This includes longer treatment timelines, greater emphasis on motivation and ambivalence, attention to adult functional contexts, and integration of medical monitoring appropriate for adults with longstanding nutritional compromise. Understanding how specialized treatment centers structure eating disorder programming can inform development of ARFID-specific tracks within existing programs.
Clinical Action Steps
If you're encountering adult patients with restrictive eating that doesn't fit the anorexia nervosa profile, start by screening for ARFID using validated tools and a structured clinical interview. Document the subtype (sensory, fear-based, lack of interest, or mixed), assess for medical complications through comprehensive laboratory screening, and evaluate functional impairment across social, occupational, and relationship domains.
Assemble a multidisciplinary treatment team including a therapist trained in CBT-AR or willing to adapt CBT principles for ARFID, a registered dietitian with eating disorder expertise, and a physician for medical monitoring. Develop an individualized treatment plan that addresses the specific ARFID subtype, incorporates motivational work if needed, and sets realistic goals for dietary expansion and functional improvement.
For patients with co-occurring autism, prioritize accommodation and harm reduction approaches. For those with significant medical compromise, consider whether a higher level of care is indicated initially. And for all adult ARFID patients, recognize that change will likely be gradual and require sustained support over months to years rather than weeks.
Get Expert Support for Adult ARFID Treatment
Treating adult ARFID requires specialized knowledge, multidisciplinary collaboration, and often a higher level of care than standard outpatient therapy can provide. If you're working with adult patients who present with ARFID or suspect you may be missing this diagnosis in your current caseload, consultation with eating disorder specialists can clarify diagnostic questions and treatment planning.
At Forward Care, we understand the complexity of adult eating disorders that fall outside traditional diagnostic categories. Our multidisciplinary team has experience assessing and treating adult ARFID across all three subtypes, with particular expertise in co-occurring autism, anxiety disorders, and medical complications from longstanding restriction.
Whether you're a clinician seeking consultation about a complex case or a provider looking to refer an adult patient who needs specialized ARFID treatment, we're here to help. Contact us today to discuss how we can support better outcomes for adults living with avoidant/restrictive food intake disorder.
